← back to search

Xingpeng Bu

Shanxi Medical University · CN
Area of research
Hematology · Physiology
Research interest
Research interests include Multiple myeloma, microRNA, Calcium, Expression (computer science), and Cancer research.
h-index
citations
5
works
1
NIH funding
primary concept
email

Recent publications

Association between inflammatory biomarkers and hypertension among sedentary adults in US: NHANES 2009–2018
Journal of Clinical Hypertension 2024cited by 10position: middledoi
Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107/ADCY1 signal
Molecular and Cellular Biochemistry 2022cited by 19position: middledoi
Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma
Frontiers in Oncology 2022cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huan‐Zhen Chen · Shanxi Medical University1 papers (2024–2024)Li Li · South China Agricultural University1 papers (2022–2022)Lihui Zhang · Hebei Agricultural University1 papers (2022–2022)Yinghua Li · Qingdao Agricultural University1 papers (2022–2022)Jinyu Wang · Fudan University1 papers (2022–2022)Yuzhu Wang · South China Agricultural University1 papers (2022–2022)Chunxia Li · Shanxi Academy of Medical Sciences1 papers (2022–2022)Lili Sun · Ministry of Education of the People's Republic of China1 papers (2022–2022)Leilei Lin · Harbin Medical University1 papers (2022–2022)Jing Xu · Duke University1 papers (2022–2022)Aiwen Wang · Ningbo University1 papers (2024–2024)Zhibo Guo · Harbin Medical University1 papers (2022–2022)Sicheng Bian · Case Western Reserve University1 papers (2022–2022)Xialin Zhang · Shanxi Medical University1 papers (2022–2022)Desheng Kong · Beijing Enterprises (China)1 papers (2022–2022)Hanbing Yao · Wenzhou Medical University1 papers (2022–2022)Nianjiao Liu · Harbin Medical University1 papers (2022–2022) · 1 papers (2022–2022)Jie Pan · Palo Alto University1 papers (2022–2022)Zhuanghui Hao · Shanxi Medical University1 papers (2022–2022)